| Tag | Content |
|---|
EnhancerAtlas ID | HS091-47438 |
Organism | Homo sapiens |
Tissue/cell | HepG2 |
Coordinate | chr9:34334200-34336220 |
Target genes | |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| HSF1 | MA0486.2 | chr9:34334274-34334287 | TTCTAGAACCTTC | + | 7.12 | | POU2F2 | MA0507.1 | chr9:34334412-34334425 | CATATTTGCATAT | + | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_32207 | chr9:34334196-34335796 | Gastric |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr9 | 34334785 | 34334867 | | chr9 | 34334897 | 34335218 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH09I034333 | chr9 | 34333861 | 34335256 |
|
Enhancer Sequence | TACCTAGGTC CCGAACCTCC TAGGCTCTGA GGGAATTGTA TTTATGGAGA AAGCCGAGAA 60
TATTTTTCCT TAGCTTCTAG AACCTTCTAA TGACATTGAA GGTTTTTTTG TTCAGGTTTT 120
TTCTAACCAC CTCAGGCACT CTGCCACTTT TTTGAAGTGT GAATTGCCTG CTGTCAGCCT 180
GGAGTTCTCA CCTCCGCAAT CCTGGCTGCA GGCATATTTG CATATTGGAT GCTGTGTTCC 240
TTAACCCCCT GAGGTTTGAA TCCACTTGGA GTCTGTGTGT GAAAGCTGGC TACTTTCAAA 300
CCCATGAACA GTTTCAGCTT TGTGGTCTCC AGAAAAACAG AAAACCCCCA ACAATAGTTC 360
CATTCACTTT TATGTAAATG GCACTCTTCA GGAAAACACT GGGCTATTTC CCAGGGCCCC 420
AGAACATACT CAAACATTTG TTTGAGTGGG AGGTGGGGAG AGAGTTCTTT TGAGTCAATG 480
AACATCTGTT CAGAACTGCT GTGCTGGGTC CCAAGAAAAC AGAGCTTATA ATCTGTCTCT 540
TCCCTGCCAG AGGTACCAGC AGAGATTTAC TATACTAGGT ATATGTGCTT GTGGTGGCAT 600
TGTACTGTGT CAGTTTAGCT AAGCTGGATT CCCAGTATCC TTCCTATCTG CTTCCAGGTG 660
AGGGTTGTCC ACAAGAAAAT TTCGTGAGAG ATTTGGAAAG CTGAATTGAA GTAGCAGCCA 720
GTACACTGTG AAGGACAGAG CAGGGTCTGT ACGCTGTGAA GGACAGAGCA GGGTACCAGG 780
CATAGTGGCA GTACCTGTAC TTTCTCTCTG ATCTGGCTCA CCTTGTTGGT GAAGGTCATC 840
ACACAGCCCC CAGCACCCCT AGCTCCTACT GAATTTCCTC CTTCAGCTCC TCTGAGTCCT 900
GGGCCATGTG TGCAGTCAGC TCTGTAGCAG AGGGCTCCGG CTTCTCCAGA TCACCTGAGT 960
CACTGAGCTT GGGACCAGTG AAAGGAAGTT GTGGGTTTCA GTTTGTCCTC ATGAGTTCCA 1020
GTTGTCCTTG TAGATCCCAG TTTGTTCTCA GAGGTTCCAG TTTGTCTTTG TTCTCTTCCA 1080
CCTCACATCC AGTTTTCTTC CCAACTGCTG GCCTCACAGA CTTCGGGCCC AACACCAGGT 1140
GCAGAGGCAG CAGAGTTGCA TGGATTTATC CACCAACTTC CAAAGATACA CAGTGTCTAC 1200
TCCTTATAAT AAATCTTTAG TTTTCTGTCA CTCATAGCGT TTGCTTCCCT GATTGAACTT 1260
TAAATTTGTT CAAGCCGTGT TAAGGATGCA GAGCATGGAA GTGATTAGAA GCCAGAAAGC 1320
TTCACAGAGG AGGTGACATC TGAGCTGCTT CTGACGAGTA GGAGGTTGTG TGTATAGAGT 1380
GGGTAGGAGG AATTCTAGAG AATAGCTGGC TCAAGCCAAG CAATTGAAAG AGCAGTGAGG 1440
AGTTCTGTAT TTCTAGAAGA ACTGTTCTTT CCATGGGTCC AGAATATAGA TGGAGAATGA 1500
GCATCTGATC CTAGCTCTTC TGGCGCCATT GAGATTAACT GTTAGCTGAT GTGGTTCTTA 1560
GATGTGGTCA TCCCTAATAC ACTGGCATCC ACTGAAATAC ATTCTTGCTA GGGTACACCC 1620
TTGTCACTAC CCTAAGATTC CTCCCCCACC CCACCGCTGC TTTCCTCTCC CCAGTGGTTC 1680
CATGTGGCTA ACCCAGGCTT GTCTTTCTTG GCTCCCCATG CAGGCATCTT TGCTTGTCCA 1740
TGTTGTGTTG ATGGTGGCAG TGGTATGGAG TTCCTGTCTT AGGCAGGGCA CTGTGCCCTC 1800
TAGTCTTGGA TCCCTAAGCT TATTTAGGGG TTCTAACATT GATTCCATGG GACCTTCTAG 1860
TCTTGGATCC CTAAGCTTAT TTAGGGGTTC TAACATTCAT TCCATGGGAC CCTCTAGTCT 1920
TGGATCCCTA AGCTTATTTA GGGGTTCTAA CATTCCATGG GACCTGAGGC AGGAGCAAGG 1980
TACCCCACAT CTATAACTTT CTAATGCTTT TTGAGCATCT 2020
|
